MedTrace Logo

Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV

NCT02846311 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2023-04-27

No results posted yet for this study

Summary

The rapid and accurate detection of influenza virus in respiratory specimens is required for optimal management of patients with acute respiratory infections. Because of the variability of the symptoms and the numerous other causes of influenza-like illness, the diagnosis of influenza cannot be made on the basis of clinical criteria alone. Thus, rapid influenza diagnostic tests have been developed such as the Alere i Influenza A\&B isothermal nucleic acid assay. Investigators prospectively evaluated the performance of the Alere i Influenza A\&B assay in comparison with the routine Xpert Flu/RSV assay.

Conditions

Interventions

DEVICE

Flu Test

Sponsors & Collaborators

  • Fondation Hôpital Saint-Joseph

    lead OTHER

Principal Investigators

  • TRABATTONI Eloïse, MD · Fondation Hôpital Saint-Joseph

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02846311 on ClinicalTrials.gov